AI Code of Conduct
Steering Committee
Committee Members
Wyatt Decker, M.D., MBA, is UnitedHealth Group’s Executive Vice President and Chief Physician, value-based care. In this role, Dr. Decker serves as the company’s lead ambassador for value-based care, working across the enterprise and externally with key stakeholders to further enable and advance accountable models of care.
Dr. Decker previously served as Chief Executive Officer of Optum Health, UnitedHealth Group’s national integrated care delivery platform. During his nearly five-year tenure, he played a vital role in building out and accelerating Optum Health’s value-based care delivery capabilities and helping over 100,000 employed and contracted physicians achieve lower costs and deliver better outcomes for more than 100 million people – including the nearly 4 million people Optum now serves in fully accountable, value-based arrangements. Under his leadership, Optum Health established national platforms for care delivery, home and community care, behavioral care, benefits chronic disease management solutions, and the Center for Advanced Clinical Solutions, applying cutting-edge technologies to solve some of health care’s toughest problems.
Prior to joining Optum, Dr. Decker served as CEO of Mayo Clinic in Arizona. In that role he established Mayo Clinic in Arizona as the safest hospital in the United States, launched a state-of-the-art cancer center, the second campus of Mayo Clinic Alix School of Medicine and was acknowledged by U.S. News & World Report among the nation’s top 20 hospitals. At Mayo Clinic, Dr. Decker pioneered the use of digital technologies, including telemedicine and artificial intelligence, to deliver health care expertise to affiliated care providers nationwide, as well as led the digital strategy around engaging and empowering patients. Dr. Decker also served as the founding chair and professor of emergency medicine at the Mayo Clinic College of Medicine where he established and directed the emergency medicine residency training program.
Dr. Decker holds an M.D. from Mayo Clinic Alix School of Medicine, an MBA from Kellogg School of Management, Northwestern University, and a Bachelor of Science from University of California, Santa Cruz. He has published numerous scientific articles and is recognized among the nation’s top 100 health care leaders by Modern Healthcare.
Dr. Sanjay Gupta is the multiple Emmy®-award winning chief medical correspondent for CNN. Gupta, a practicing neurosurgeon, plays an integral role in CNN’s reporting on health and medical news for all of CNN’s shows domestically and internationally, and regularly contributes to CNN.com.
In addition to his work for CNN, Gupta is an associate professor of neurosurgery at Emory University Hospital and associate chief of neurosurgery at Grady Memorial Hospital in Atlanta. He serves as a diplomate of the American Board of Neurosurgery. And in 2019, Gupta was elected to the National Academy of Medicine, considered one of the highest honors in the medical field.
Gupta is the author of three New York Times best-selling books, “Chasing Life” (2007), “Cheating Death” (2009) and “Monday Mornings” (2012). His fourth book, “Keep Sharp: Building a Better Brain” will be published in 2021. Gupta received his undergraduate degree from the University of Michigan and a Doctorate of Medicine degree from the University of Michigan Medical School.
COI: None noted.
Eric Horvitz, MD, PhD, serves as Microsoft’s Chief Scientific Officer, guiding strategic scientific initiatives companywide. He serves on the NIH Advisory Committee to the Director working group on AI and previously served on the President’s Council of Advisors on Science and Technology (PCAST), co-leading studies in healthcare and biosciences. Dr. Horvitz has also served as President of the Association for the Advancement of AI (AAAI), Commissioner on the National Security Commission on AI, and on the Board of Regents of the National Library of Medicine. His research spans machine learning, reasoning, and human-AI interaction. For decades, he has advanced AI applications in healthcare settings. Dr. Horvitz’ foundational contributions include probabilistic and decision-theoretic reasoning, bounded rationality, and human-AI complementarity. His honors include the Feigenbaum Prize and Allen Newell Prize for his contributions in AI, induction into the CHI Academy for advances in human-AI collaboration, election as a member of the National Academy of Engineering, American Academy of Arts and Sciences, and American Philosophical Society, and as a fellow of AAAI, Association for Computing Machinery, Association for the Advancement of Science, and the American College of Medical Informatics. He co-founded the Partnership on AI and initiated Stanford’s One Hundred Year Study on AI. At Microsoft, he established the Aether Committee, advising on AI safety, trustworthiness, and ethics, and co-founded the Office of Responsible AI, overseeing policies and compliance across company products and services.
Kevin B. Johnson, MD, MS, FAAP, FACMI, is the David L. Cohen University Professor of Biomedical Informatics, Computer Science, Pediatrics, and Science Communication at the University of Pennsylvania, and Vice President of Applied Clinical Informatics in the University of Pennsylvania Health System. Dr. Johnson is an internationally respected expert in clinical informatics. His current research focuses on clinical documentation and AI. He was among the world’s first researchers to propose and demonstrate the value of text-messaging in behavior change. Previously, Dr. Johnson served as Chair for the Department of Biomedical Informatics and Chief Informatics Officer for Vanderbilt University Medical Center, and holds numerous national leadership positions and serves on various advisory boards. He is passionate about educating lay audiences about informatics. He has produced documentaries related to health information technology. His podcast, “Informatics in the Round” features experts discussing informatics topics to songwriters. Most recently, Dr. Johnson co-published a book series called “Who, Me?” featuring scientists from marginalized groups, encouraging young children to consider careers in STEMM. He has authored over 200 publications and has won numerous national awards. Dr. Johnson was elected to the American College of Medical Informatics in 2004 (FACMI) and (FAMIA), The Academic Pediatric Society in 2010, the National Academy of Medicine in 2010, the International Association of Health Science Informatics in 2021 (FIAHSI), and the American Institute of Medical and Biological Engineering in 2022 (FAIMBE).
Philip R. O. Payne, PhD, serves as the Chief Health AI Officer for BJC Health System and Washington University School of Medicine, and he is the founding director of their joint Center for Health AI. He also holds the Janet and Bernard Becker Professorship and is the founding director of the Institute for Informatics, Data Science and Biostatistics (I2DB) at WashU Medicine. Additionally, Dr. Payne is a professor of general internal medicine and computer science and engineering. With over 300 publications, he leads a dynamic research group that addresses areas such as: 1) AI-driven methods for discovering and analyzing biomolecular and clinical phenotypes, 2) interventional applications of electronic health records and clinical decision support, 3) human factors and workflow optimization in healthcare IT, and 4) the development and assessment of data sharing and analytics platforms to support high-value, agile healthcare systems and research initiatives. Dr. Payne is an elected fellow of the American College of Medical Informatics, American Medical Informatics Association (AMIA), American Institute for Medical and Biological Engineering, and the International Academy of Health Sciences Informatics. He currently serves as president-elect of the AMIA, the leading professional organization in Biomedical and Health Informatics. Beyond academia, Dr. Payne is an active entrepreneur, founding multiple digital health companies and serving in advisory and governance roles with various health and life sciences companies and venture capital firms.
Vardit Ravitsky, PhD, is President and CEO of the Hastings Center for Bioethics, an independent, nonpartisan bioethics research institute that is among the most prestigious bioethics and health policy institutes in the world. She is Senior Lecturer on Global Health and Social Medicine at Harvard Medical School, and was a Full Professor at the Bioethics Program, School of Public Health, University of Montreal. She is Past-President of the International Association of Bioethics, and a Fellow of the Canadian Academy of Health Sciences and of The Hastings Center. Dr. Ravitsky’s research focuses on the ethics of genomics and reproduction, as well as the use of AI in biomedical research. It is funded by Canada’s leading funding agencies and the NIH. She has published over 200 articles and commentaries on bioethical issues and has given over 300 talks worldwide and over 400 media interviews. Her research covers a variety of topics such as public funding of In-Vitro Fertilization; the use of surplus frozen embryos; posthumous reproduction; pre-implantation genetic testing; gamete donation; epigenetics; prenatal testing, particularly the ethical, social, and legal aspects of Non-Invasive Prenatal Testing (NIPT); germline and somatic gene editing; mitochondrial replacement, and the use of Artificial Intelligence in biomedical research. Recently, Dr. Ravitsky has been involved in research and policy regarding pandemic ethics and was heavily involved in public outreach during COVID-19. She is a Principal Investigator on two Bridge2AI research projects funded by the National Institutes of Health that expand the use of AI in biomedical and behavioral research. She serves on the steering committee of the National Academy of Medicine (NAM) to develop an Artificial Intelligence Code of Conduct (AICC). Previously, she was Fellow at the Department of Bioethics at the NIH and faculty at the Department of Medical Ethics, School of Medicine, at the University of Pennsylvania. She was also a Senior Policy Advisor at CIHR’s Ethics Office and a GE3LS consultant to Genome Canada (GE3LS=genomics and its ethical, economic, environmental, legal, and social implications).
Suchi Saria, PhD, holds a John C. Malone endowed chair and is the Director of AI and health lab at Johns Hopkins where she is jointly appointed as faculty in Computer Science, Medicine and Health Policy. She is also the founder of Bayesian Health, a clinical AI platform company spun out of Hopkins that augments care teams by bringing together state of the AI/ML technology combined with responsible AI best practices to dramatically improve quality while saving clinicians’ time. Dr. Saria’s work in AI over the last two decades has led to foundational advances in technology, best practices around translation, and AI policy. She has written several seminal papers in AI/ML around issues of learning robust models, detecting drifts, monitoring and learning from messy real-world datasets. Her applied research has built on these technical advances to develop novel next generation diagnostic and treatment planning tools that use AI/ML to individualize care. Her work has been funded by leading organizations including the NSF, DARPA, FDA, NIH and CDC and she regularly serves as a scientific advisor to leading Fortune 500 companies. Dr. Saria completed her PhD in AI at Stanford. In 2024, she received an honorary doctorate from Mount Holyoke. She’s a Sloan Research Fellow, named by IEEE to “AI’s 10 to Watch”. Modern Healthcare’s Top 25 Innovators, World Technology Forum’ Technology Pioneer, and her work was recognized as one of TIME’s Best Inventions in 2023 and 2024. She is on the board of the Coalition of Health AI (CHAI), editorial board of the Journal of Machine Learning Research and serves on the National Academy of Medicine AI Code of Conduct.
Peter Lee is President, Microsoft Research, at Microsoft. He leads Microsoft Research across its nine laboratories around the world. He also oversees several incubation teams for new research-powered lines of business, the largest of which today is Microsoft’s growing healthcare and life sciences effort. Dr. Lee has extensive experience in managing fundamental research to commercial impact in a range of areas, spanning artificial intelligence, to quantum computing, to biotechnology, and more. Before joining Microsoft in 2010, he was at DARPA, where he established a new technology office that created operational capabilities in machine learning, data science, and computational social science. From 1987 to 2005 he was a Professor at Carnegie Mellon University, and from 2005 to 2008 the Head of the university’s computer science department. Today, in addition to his management responsibilities, Dr. Lee speaks and writes widely on technology trends and policies. He is a member of the National Academy of Medicine. He serves on the Boards of Directors of the Allen Institute for Artificial Intelligence, the Brotman Baty Institute for Precision Medicine, and the Kaiser Permanente Bernard J. Tyson School of Medicine. In public service, Dr. Lee was a commissioner on President Obama’s Commission on Enhancing National Cybersecurity and led several studies for both PCAST and the National Academies on the impact of federal research investments on economic growth. He has testified before both the US House Science and Technology Committee and the US Senate Commerce Committee.
Kenneth D. Mandl, MD, MPH is a Professor at Harvard Medical School (HMS) and the Director at Boston Children’s Hospital Computational Health Informatics Program. Recognized for research and teaching, Mandl received the Presidential Early Career Award for Scientists and Engineers and the Clifford A. Barger Award for top mentors at Harvard Medical School. He was advisor to two Directors of the CDC and chairs the Board of Scientific Counselors of the NIH’s National Library of Medicine. Dr. Mandl has been elected to multiple honor societies including the American Society for Clinical Investigation, Society for Pediatric Research, American College of Medical Informatics and American Pediatric Society. Mandl leads two postdoctoral training programs in clinical and informatics research and directs the Population Health Track of the new Masters Degree in Biomedical Informatics at HMS. Mandl is a faculty member in the HMS Center for Biomedical Informatics and in the Division of Health Sciences and Technology at Harvard and MIT. Through scholarship intersecting epidemiology and informatics, Mandl pioneered use of IT and big data for population health, discovery, patient engagement and care redesign. Mandl leads the transformative SMART Platforms initiative to design the “app store for health” and is principal investigator of the Scalable Collaborative Infrastructure for a Learning Health System across Boston hospitals and nationally. Recognized for research and teaching, Mandl received the Presidential Early Career Award for Scientists and Engineers and the Clifford A. Barger Award for top mentors at Harvard Medical School. He was advisor to two Directors of the CDC and chairs the Board of Scientific Counselors of the NIH’s National Library of Medicine. His clinical training and experience is in pediatrics and pediatric emergency medicine. Dr. Mandl has been elected to multiple honor societies including the American Society for Clinical Investigation, Society for Pediatric Research, American College of Medical Informatics and American Pediatric Society.
